Association of metformin use with Alzheimer’s disease in patients with newly diagnosed type 2 diabetes: a population-based nested case–control study

Metformin reduces insulin resistance, which constitutes a pathophysiological connection of diabetes with Alzheimer’s disease (AD), but the evidence of metformin on AD development was still insufficient and conflicting. We investigated AD risk in patients with newly diagnosed type 2 DM treated with m...

Descripción completa

Detalles Bibliográficos
Autores principales: Ha, Junghee, Choi, Dong-Woo, Kim, Kwang Joon, Cho, So Yeon, Kim, Hyunjeong, Kim, Keun You, Koh, Youngseung, Nam, Chung Mo, Kim, Eosu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8674300/
https://www.ncbi.nlm.nih.gov/pubmed/34912022
http://dx.doi.org/10.1038/s41598-021-03406-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8674300/
https://www.ncbi.nlm.nih.gov/pubmed/34912022
http://dx.doi.org/10.1038/s41598-021-03406-5

Ejemplares similares